“Committed to Excellence in Life Sciences Executive Search”
Akcea Therapeutics
Categories: Life Sciences, Pharmaceutical
Client: Akcea Therapeutics
Akcea Therapeutics has retained The Chase Group to secure a Chief Medical Officer to join the start-up organization. This person will be responsible for the overall strategic direction for development products and programs across all stages of development. These responsibilities will cover the full scope of clinical development functions including pre-clinical activities, Phase I (including human PK/PD) studies, as well as Phase II-IV trial design and execution. This position will work closely with the development teams ensuring effective strategy, design, execution and regulatory submission of development programs.
Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that has the potential to address unmet medical needs in neuroscience….
The Chase Group (TCG) is pleased to announce the successful recruitment of David Geller, MD as the Vice President, Pulmonary and Rare Diseases Clinical Development…
Ionis Pharmaceuticals retained The Chase Group to identify and secure the next member of their drug safety leadership team to support a robust and continually…
The Chase Group, known for its thorough search capabilities and expertise in Life Sciences Executive Search, was retained by Genmab Pharmaceuticals to execute a critical…
Building on a 14+ year relationship with Chase, the Chief Medical Officer of Checkmate Pharmaceuticals retained The Chase Group to identify a critical hire for…
The Chase Group was once again retained by Akcea Therapeutics to complete an extensive executive search on an accelerated timeline for a Senior Vice President,…